Dermatologic-disorders
PubMed Central: Published
on August, 2022TAKE HOME MESSAGE:Seborrheic dermatitis (SD) is a
common chronic inflammatory skin disorder that mostly affects young adults in
areas rich in sebaceous glands (scalp, face, and trunk). In adolescents and adults, SD
clinical presentation may range from mild patches to diffuse scalp scaling. In
infants, i...
PubMed Central: Published on January 2019Tinea (Pityriasis) Versicolor is a
common, chronic, superficial fungal infection caused by Malassezia spp.
It is characterised by hyperpigmented, hypopigmented macules and patches on the
face, upper trunk, back, chest paralleling the density of sebaceous gland. Several topical and systemic
antifungal age...
American Family
Physician (AFP) Journal:Seborrhoeic Dermatitis (SD) is a very common chronic and/or
relapsing inflammatory skin disorder presenting with a papulosquamous
morphology in areas rich in sebaceous glands, particularly the scalp, face, and
body folds.In adolescents and adults, SD clinical presentation may range
from mild patches to d...
Journal of the European
Academy of Dermatology and Venereology (JEADV): Published on November, 2021Tinea capitis is a highly contagious scalp condition that is
common in children 3-7 years of age but can be found in all ages. It can
present with a spectrum ranging from scaly, patchy alopecia with or without
"blackdots" to purulent inflammation...
The Journal of Dermatology: June, 2022Coronavirus disease 2019 (COVID-19)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
declared a pandemic by the World Health Organization, and COVID-19 continues to
have a major impact on society. Numerous studies have reported
impaired health sequelae after COVID-19 recovery, one...
PubMed Central: BMJ Clinical EvidenceSeborrhoeic dermatitis affects at
least 3% to 10% of the population and causes red patches with greasy scales on
the face, chest, skin flexures, and scalp.The cause of seborrhoeic dermatitis
is unknown. Malassezia yeast species are thought to have an
important role.The inflammatory process may be
mediated i...
BioMed Central (BMC Dermatol) Journal: ECTODERM
IndiaSuperficial fungal infections are caused by dermatophytes,
non-dermatophytic moulds and commensal yeasts. Dermatophytes, the most common
causative agents, are assuming high significance in developing countries like
India.Currently, dermatologists across India are inundated with
cases of derm...
International Journal
of Research in Dermatology (IJORD): Published on May, 2021The number of
new cases of dermatophytosis on
the rise but also
a humungous number of
patients are experiencing
a great degree
of relapses and recurrences.
Causes like drug
resistance, poor drug compliance, inadequate...
Indian Journal of Dermatology: Published on July, 2020A Randomized Controlled Parallel
Group Open Labeled Trial with Clinico-Mycological Correlation.Tinea is a superficial fungal
infection caused by dermatophytes which invade and multiply within the
keratinized tissue (skin, hair, nails). Approximately 20%-25% of the world population
is affecte...
Pediatric Dermatology: Published on November 2020Head and neck dermatitis (HND) is a clinical variant of
atopic dermatitis (AD), presenting in adolescence or adulthood and
characterized by involvement of the head, neck, and superior part of the trunk.
The role of Malassezia spp has been advocated in the
pathogenesis of HND, and antifungal agent...
JAMA Dermatology: Published on September 28, 2022With worldwide emergence of recalcitrant and resistant
dermatophytosis, itraconazole is increasingly being used as the first-line drug
for treatment of tinea corporis/cruris (TCC). Apparent inadequacy with low doses has led to empirical use
of higher doses and antifungal combinations.This study ai...
FRONTLINE MEDICAL NEWS – Dr.
Boni E. Elewski.Luliconazole
(NULIZA ®) has something unique
to offer when it comes to treating tinea pedis. This is an azole drug, meaning
it is broad spectrum and kills dermatophytes, yeast, and molds. Also, like all
azoles, it has some antibacterial activity.
The generic Luliconazole
(NULIZA ®) is approved f...
